LITFULO (ritlecitinib) is a prescription medicine used to treat severe alopecia areata in adults and adolescents 12 years and older.

Jun 27, 2023 · Litfulo (ritlecitinib) and Olumiant (baricitinib) are both oral medications that may be used to treat certain autoimmune conditions. Olumiant is a Janus kinase (JAK) inhibitor, and …

LITFULO (ritlecitinib) capsules are formulated with ritlecitinib tosylate, a kinase inhibitor. Ritlecitinib tosylate is a white to off white to pale pink solid which is freely soluble in water.

LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older. (1) Limitations of Use: Not recommended for use in …

Nov 24, 2024 · Find patient medical information for Litfulo (ritlecitinib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Ritlecitinib, sold under the brand name Litfulo, is a medication used for the treatment of severe alopecia areata (hair loss). [6] Ritlecitinib is a kinase inhibitor which inhibits Janus kinase 3 …

LITFULO® (ritlecitinib) What is the most important information I should know about LITFULO? What is the most important information I should know about LITFULO? LITFULO may cause …

LITFULO (ritlecitinib) FAQ Click to download the LITFULO FAQ What is LITFULO? LITFULO (Ritlecitnib) is a selective dual Janus kinase 3 (JAK3) and tyrosine protein (TEC) kinase …

Learn important info about potential side effects for LITFULO® and safety for this once-daily prescription for people ages 12+ with severe alopecia areata.

Mar 3, 2025 · Overview Litfulo is a medicine used to treat adults and adolescents over 12 years of age with severe alopecia areata, an autoimmune disease (a disease caused by the body’s …